Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00653991 · ClinicalTrials.gov registry record · NA

The SOLVE-IT National Randomized Trial

A NA study of HIV Infections, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
2,020
Enrollment target
1
Study location

NCT00653991: Completed NA study of HIV Infections, sponsored by University of Southern California.

NCT00653991 is a NA study of HIV Infections that has completed, run by University of Southern California. The registered enrollment target is 2,020 participants, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (357% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00653991, a NA study of HIV Infections, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
2,020 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of an interactive virtual environment computer game in reducing risky sexual behaviors among men who have sex with men.

Primary Outcome

Counts of unprotected anal intercourse (one each for insertive and receptive; UAI) in the past 3 months with a non-primary partner were reported by participants at baseline, and 3 month follow-up. Reports of insertive and receptive anal intercourse per time period were summed. Change in unprotected anal intercourse was calculated at 3 months using residualized change scores (regressing 3-month reported UAI (Y) on baseline UAI. Negative numbers reflect a reduction in UAI over time). Although raw

Conditions Studied

Interventions

  • BEHAVIORAL SOLVE-IT

Study Locations (1)

California

  • University of Southern California (University Village) - Los Angeles

Trial Details

FieldValue
Enrollment Target 2,020 participants
Start Date 2011-06
Est. Completion 2013-05
Phase NA
University of Southern California

617 total trials

What the finished NCT00653991 record still lists

NCT00653991 is an interventional study that assigns participants to a tested intervention. Its 2,020 participants enrollment target places it among the larger protocols in the corpus, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (357% higher).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which SOLVE-IT is the first listed.

NCT00653991 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00653991 about?

NCT00653991 is a clinical study titled "The SOLVE-IT National Randomized Trial". This study will evaluate the effectiveness of an interactive virtual environment computer game in reducing risky sexual behaviors among men who have sex with men.

What is the current status of trial NCT00653991?

This trial is currently completed. It is a NA study. The enrollment target is 2,020 participants. The study started on 2011-06. Estimated completion is 2013-05.

What conditions does trial NCT00653991 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00653991?

The interventions under investigation include: SOLVE-IT (BEHAVIORAL).

Who is sponsoring clinical trial NCT00653991?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00653991 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00653991's enrollment target sits among peer trials

2,020 11th of 542 higher than 532 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05059444 · 2,020 participants

    ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • NCT04216732 · 2,030 participants

    Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

  • NCT04604509 · 2,010 participants · Phase 4

    Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

  • NCT04100564 · 2,009 participants · NA

    LITES Task Order 0005 Prehospital Airway Control Trial (PACT)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00653991, the US trial registry maintained by the National Library of Medicine. NCT00653991 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.